5 A Toolkit for Health Care Professionals Unmet Needs in Hypertension Erika R. Drury, MD, is an assistant professor of medicine in the Division of Nephrology at the University of Rochester in Rochester, New York. She is the assistant director of the hypertension program at the University of Rochester, an American Heart Association Comprehensive Hypertension Center. Her practice focuses on difficult-to-treat hypertension, including resistant hypertension and management of blood pressure in chronic kidney disease and end-stage renal disease. Disclosures: Professional Services and Activities – Employment: University of Rochester Medicine Mulubrhan F. Mogos, PhD, MSc, FAHA, is an assistant professor at Vanderbilt University School of Nursing. His research focuses on pregnancy-related cardiovascular health, with particular emphasis on hypertensive disorders of pregnancy. He investigates the health effects of behavioral, biological and environmental factors on maternal cardiovascular health, and he explores potential interventions that reduce cardiovascular disease, including hypertension risk among women. Disclosures: Professional Services and Activities – Employment: Vanderbilt School of Nursing Mary L. Velasquez, RN, MS, ACNP-BC, is a CPC/STEMI/ PSC program manager and coordinator for Teleneurology Services and Cardiovascular Data Registries at Sutter Health. As a cardiovascular clinician, Velasquez is a cardiovascular team member of the American College of Cardiology and the American Heart Association and Western States: Quality, Outcomes Research and Analytics Task Force. She has managed cardiac clinical research and is an expert in program development. Disclosures: Professional Services and Activities – Employment: Sutter Health Relationship disclosures within the past 24 months: The American Heart Association is committed to ensuring balance, independence, objectivity and scientific rigor in its certified educational activities. All faculty, planners and contributors in a position to control the content for an AHA-sponsored activity are required to disclose to the activity audience any financial relationships regardless of the amount during the prior 24 months with (1) the manufacturer(s) of any ineligible company product(s) and/or interest(s) of ineligible companies regardless of relation to the content of the activity and (2) any ineligible company supporters of the activity. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the faculty must disclose that the product is not labeled for the use under discussion or that the product is still investigational.
RkJQdWJsaXNoZXIy MjI2NjI=